Drinking Water Contaminant Candidate List - Draft; Notice of Availability

The Attorney General of Missouri, representing fourteen other states, requests that the EPA amend the 6th Contaminant Candidate List to include the abortion drug mifepristone and its generics. They argue that the drug is an endocrine disruptor that persists in the water supply and poses significant health risks to pregnant women and the general public.

The American Association of Pro-Life Obstetricians and Gynecologists (AAPLOG) urges the EPA to add mifepristone to the Drinking Water Contaminant Candidate List. They argue that the drug's potency as a progesterone antagonist and its widespread use necessitate federal evaluation of its potential impact on reproductive health and fetal development.

A group of members of the United States Congress is requesting that the EPA add the chemical abortion drug mifepristone to the Contaminant Candidate List (CCL 6). They argue that the drug's presence in the environment from excretion and manufacturing poses a potential risk to public drinking water and health that requires research and monitoring.

The Ethics and Public Policy Center (EPPC) urges the EPA to include the abortion drug mifepristone on the Drinking Water Contaminant Candidate List 6. They argue that the drug is an unregulated pharmaceutical that warrants further study due to its potential for environmental contamination and its relevance to sensitive subpopulations.

The Guttmacher Institute, a research and policy organization, opposes the inclusion of mifepristone and other abortion medications in the Drinking Water Contaminant Candidate List. They argue that there is no scientific evidence of environmental harm from these medications and that their inclusion is a politically motivated attempt to stigmatize and restrict abortion access.

A concerned resident is requesting that the EPA add mifepristone and its metabolites to the Drinking Water Contaminant Candidate List. The commenter argues that monitoring these compounds is necessary to determine if wastewater treatment systems are effectively removing them and to ensure public transparency regarding water safety.

A taxpayer is requesting that the EPA add mifepristone and its metabolites to the Drinking Water Contaminant Candidate List. The commenter argues that the agency should use its authority to monitor these substances to protect public health and prevent water-quality issues.

An individual supporter of the "Make America Healthy Again" agenda urges the EPA to include mifepristone and its metabolites on the Drinking Water Contaminant Candidate List. The commenter argues that the agency should proactively monitor these substances to protect public health and environmental stewardship.

A Virginia resident is requesting that the EPA add mifepristone and its metabolites to the Drinking Water Contaminant Candidate List. The commenter argues that federal monitoring is necessary to ensure water safety and protect families from potential pollution.